Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.1K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

705
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
705
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developing low-carbon salbutamol MDI: assessment of relative bioavailability and pharmacodynamic relative potency of salbutamol MDI with propellant HFA-152a.

BMJ open respiratory research·2026
Same author

Airborne Movement of Antibiotic Resistance Genes Between Livestock Stables and Farmers' Homes.

Microorganisms·2026
Same author

Psychological distress and tumor cell β2-adrenergic receptor levels in patients with surgically resected non-small cell lung cancer.

Acta oncologica (Stockholm, Sweden)·2026
Same author

Associations between respiratory health, reported traffic, and occupational-related exposure.

European clinical respiratory journal·2026
Same author

Prognostic Value of Impaired Spirometry in Patients with Myocardial Infarction: A Longitudinal Study of Two European Cohorts.

International journal of chronic obstructive pulmonary disease·2026
Same author

Associations Between Different Eosinophil Activity Markers and Clinical Outcomes in Young Asthmatics.

Clinical and translational allergy·2026

Related Experiment Video

Updated: Jan 9, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.3K

Health Status Instruments Add Prognostic Value in Predicting COPD Exacerbations: Insights from the TIE Cohort Study.

Andreas Palm1, Jens Ellingsen1, Kristina Bröms2

  • 1Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.

COPD
|December 4, 2025
PubMed
Summary
This summary is machine-generated.

Three health status instruments, modified Medical Research Council Dyspnoea scale (mMRC), COPD Assessment Test (CAT), and Clinical COPD Questionnaire (CCQ), effectively predict acute exacerbations of COPD (AECOPDs). These tools offer valuable insights for identifying at-risk patients.

Keywords:
CATCCQCOPD exacerbationshealth status instrumentsmMRC

More Related Videos

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
06:22

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections

Published on: September 19, 2025

406
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

1.3K

Related Experiment Videos

Last Updated: Jan 9, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.3K
Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
06:22

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections

Published on: September 19, 2025

406
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

1.3K

Area of Science:

  • Pulmonary Medicine
  • Clinical Epidemiology

Background:

  • Identifying patients at risk for acute exacerbations of Chronic Obstructive Pulmonary Disease (AECOPDs) is critical for improving patient outcomes.
  • Health status instruments are increasingly used to assess COPD severity and predict exacerbations.

Purpose of the Study:

  • To evaluate the predictive ability of three health status instruments for AECOPDs.
  • To assess these instruments in patients with and without a history of prior AECOPDs.

Main Methods:

  • A prospective cohort study was conducted with 572 COPD patients in Sweden.
  • The modified Medical Research Council Dyspnoea scale (mMRC), COPD Assessment Test (CAT), and Clinical COPD Questionnaire (CCQ) were assessed.
  • Receiver operator characteristic (ROC) curves and Cox regression models were used to estimate prediction thresholds and values.

Main Results:

  • All three instruments (mMRC ≥ 2, CAT ≥13, CCQ ≥ 1.6) independently predicted future AECOPDs within three years (aHR 1.5-1.8).
  • Patients with high scores but no prior AECOPDs showed similar risk to those with prior AECOPDs but low scores.
  • Among patients with prior AECOPDs and elevated scores on at least one instrument, the risk of future AECOPDs was significantly higher (aHR 4.6-5.7).

Conclusions:

  • The mMRC, CAT, and CCQ are independently associated with future AECOPDs over a three-year period.
  • These health status instruments provide additional predictive value for AECOPDs, irrespective of prior exacerbation history.